co.don AG Stock price Xetra

Equities

CNWK

DE000A1K0227

Pharmaceuticals

End-of-day quote Xetra 06:00:00 2022-09-29 pm EDT 5-day change 1st Jan Change
0.245 EUR -28.99% Intraday chart for co.don AG -25.76% -.--%
Sales 2020 6.23M 6.73M Sales 2021 9.8M 10.59M Capitalization 33.89M 36.6M
Net income 2020 -13M -14.04M Net income 2021 -9M -9.72M EV / Sales 2020 6.74 x
Net cash position 2020 3.15M 3.4M Net cash position 2021 293K 316K EV / Sales 2021 3.43 x
P/E ratio 2020
-2.91 x
P/E ratio 2021
-3.8 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 38.31%
More Fundamentals * Assessed data
Dynamic Chart
Co.don AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal particular cartilage defects, lumbar disc herniation, non-union fractures and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, particularly in the knee area; co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. The Company is active domestically and in other European countries.
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock co.don AG
  4. Stock co.don AG - Xetra